dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Rischin, Danny |
dc.contributor.author | Gil-Martin, Marta |
dc.contributor.author | González-Martin, Antonio |
dc.contributor.author | Braña Garcia, Irene |
dc.contributor.author | Hou, June Y. |
dc.contributor.author | Cho, Daniel |
dc.date.accessioned | 2021-09-21T10:50:33Z |
dc.date.available | 2021-09-21T10:50:33Z |
dc.date.issued | 2020-11-01 |
dc.identifier.citation | Rischin D, Gil-Martin M, González-Martin A, Braña I, Hou JY, Cho D, et al. PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer. Gynecol Oncol. 2020 Nov 1;159(2):322–8. |
dc.identifier.issn | 0090-8258 |
dc.identifier.uri | https://hdl.handle.net/11351/6339 |
dc.description | Cemiplimab; Càncer de coll uterí metastàtic; Càncer de coll uterí recurrent |
dc.description.sponsorship | This study was funded by Regeneron Pharmaceuticals , Inc. and Sanofi. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Gynecologic Oncology;159(2) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Coll uterí - Càncer - Tractament |
dc.subject.mesh | Uterine Cervical Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Carcinoma, Squamous Cell |
dc.title | PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.ygyno.2020.08.026 |
dc.subject.decs | neoplasias del cuello uterino |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | carcinoma de células escamosas |
dc.relation.publishversion | https://doi.org/10.1016/j.ygyno.2020.08.026 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Rischin D] Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia. [Gil-Martin M] Institut Català d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain. [González-Martin A] Clinica Universidad de Navarra, Madrid, Spain. [Braña I] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Hou JY] Division of Gynecologic Oncology, Columbia University Medical Center, New York, NY, USA. [Cho D] Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY, USA |
dc.identifier.pmid | 32917410 |
dc.identifier.wos | 000580586500069 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |